Searched for
ELI LILLY COMPETITION
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- US stocks: Musk's SpaceX prices record $75 billion IPO at $135 a shareSpaceX has priced its record-breaking U.S. IPO at $135 per share, raising $75 billion and valuing the company at $1.77 trillion. This makes...
- Why is US stock market down today? Dow Jones, S&P 500 and Nasdaq fall as inflation hits three-year high and Iran tensions shake Wall Street - Nvidia, Amazon and technology stocks leading today's declineUS stock market is under pressure again. Investors woke up to another sharp decline in the Dow Jones, S&P 500 and Nasdaq after fresh inflat...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- Eli Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarityEli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...
- Eli Lilly Foundayo weight-loss pill vs Novo Nordisk Wegovy oral obesity treatment tablets: Which medicine is the most prescribed across U.S.?Eli Lilly Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started on A...
- India is well positioned to attract future investments, says Eli Lilly's Patrik JonssonEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for data pro...
- India is well positioned to attract future investments: Patrik Jonsson, President, Lilly InternationalEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for stronger...
- Why did NVO stock crash over 14% today? Novo Nordisk’s weight-loss drug CagriSema misses trial goal against Eli Lilly’s TirzepatideNVO stock today: Novo Nordisk shares plummeted after its next-generation weight loss drug, CagriSema, failed to achieve non-inferiority in ...
- Eli Lilly becomes first healthcare firm to hit $1 trillion market cap - here’s why LLY stock has jumped over 36% this yearEli Lilly stock today: Eli Lilly achieved a historic milestone, briefly touching a $1 trillion market cap. This success is driven by strong...
- Eli Lilly and Visa expected to hit $1 trillion valuation by 2030: Here’s what’s driving the surgeAs global equity markets expand, two corporate heavyweights are emerging as serious contenders to reach $1 trillion in market capitalizatio...
- Popular US-based weight loss drug maker Eli Lilly plans to launch medicine in India next yearEli Lilly will launch Mounjaro in India in 2025. The drug treats type 2 diabetes and obesity. Lilly received marketing authorization in Jul...
- Eli Lilly announces $27-billion US expansion: To add 13,000 jobs and new manufacturing sitesEli Lilly & Co has announced a $27-billion expansion of its US manufacturing operations, adding four new sites and creating 13,000 jobs. Th...
- Investors increase holdings of weight-loss drug makers' shares in Q3Shares of both companies have soared this year as Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Mounjaro and Zepbound have been shown t...
- Bajaj Healthcare moves Indian patent office for compulsory licence for Covid drugEli Lilly & Company declined the applications on both the occasion, citing the reason that it is really challenging for them to sign volunt...
- Novartis completes transcation to sell animal health business to Elanco IndiaNovartis India has completed the transaction to sell its animal health business to Elanco India, an affiliate of Eli Lilly.
- Elanco gets FIPB nod to acquire Novartis' animal health businessElanco India is now awaiting approval from the Competition Commission of India after which both the companies will close the transaction, i...
- HCL Tech in pact with Eli Lilly for developing technologiesHCL and Eli Lilly entered into a partnership for developing technologies & improving operational efficiencies to enhance latter's global co...
Load More
